Alto Neuroscience (ANRO) Cash from Investing Activities (2023 - 2026)
Alto Neuroscience has reported Cash from Investing Activities over the past 4 years, most recently at -$556000.0 for Q1 2026.
- Quarterly results put Cash from Investing Activities at -$556000.0 for Q1 2026, down 2216.67% from a year ago — trailing twelve months through Mar 2026 was -$556000.0 (up 70.35% YoY), and the annual figure for FY2025 was -$24000.0, up 98.84%.
- Cash from Investing Activities reached -$556000.0 in Q1 2026 per ANRO's latest filing, down from -$24000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$21000.0 in Q1 2023 and bottomed at -$1.0 million in Q3 2024.
- Median Cash from Investing Activities over the past 4 years was -$282000.0 (2024), compared with a mean of -$312500.0.
- The largest annual shift saw Cash from Investing Activities plummeted 2237.21% in 2024 before it surged 89.29% in 2025.
- Over 4 years, Cash from Investing Activities stood at -$352000.0 in 2023, then tumbled by 43.75% to -$506000.0 in 2024, then soared by 95.26% to -$24000.0 in 2025, then tumbled by 2216.67% to -$556000.0 in 2026.
- Business Quant data shows Cash from Investing Activities for ANRO at -$556000.0 in Q1 2026, -$24000.0 in Q1 2025, and -$506000.0 in Q4 2024.